chr1-90939235-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_201269.3(ZNF644):c.2119A>G(p.Lys707Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00412 in 1,614,010 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_201269.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00323 AC: 491AN: 152122Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00364 AC: 912AN: 250860Hom.: 2 AF XY: 0.00375 AC XY: 509AN XY: 135734
GnomAD4 exome AF: 0.00421 AC: 6157AN: 1461770Hom.: 20 Cov.: 34 AF XY: 0.00419 AC XY: 3048AN XY: 727180
GnomAD4 genome AF: 0.00323 AC: 492AN: 152240Hom.: 1 Cov.: 32 AF XY: 0.00359 AC XY: 267AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
ZNF644-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at